Atlas Genetics has appointed its new chief executive officer in the form of Jeffrey Luber, as he succeeds Dr John Clarkson who transitions into executive chairman.
Luber also joins the company’s board following experience in the life sciences industry and holding multiple leadership roles including CEO of EXACT Sciences.
He said: “I am thrilled to join Atlas Genetics given the power of its platform, the strength of its board and leadership team, and its experience investor syndicate.
“As diagnostic testing increasingly becomes more decentralised, I look forward to working with the team to make Atlas the leading global player in POC testing.”
Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and Amazon.
Dr John Clarkson, founding CEO, Atlas Genetics, said: “Jeff’s proven track record and extensive experience in the commercialisation of in vitro diagnostics will be invaluable as we enter the next, exciting phase of growth aimed at improving the diagnosis and treatment of conditions affecting women and families.”